tiprankstipranks
Callan JMB, Inc. (CJMB)
NASDAQ:CJMB
US Market
Want to see CJMB full AI Analyst Report?

Callan JMB, Inc. (CJMB) AI Stock Analysis

33 Followers

Top Page

CJMB

Callan JMB, Inc.

(NASDAQ:CJMB)

Select Model
Select Model
Select Model
Neutral 51 (OpenAI - Gpt-5.6Sol)
Rating:51Neutral
Price Target:
$2.50
▲(19.05% Upside)
Action:Reiterated
Date:08/24/26
The score is held down primarily by sharply weakened financial performance (major revenue contraction, sustained losses, negative TTM operating/free cash flow, and eroded equity). Technical momentum is currently supportive (price above key DMAs with positive MACD), but valuation is constrained by negative earnings, and corporate events are mixed with both financing/expansion upside and Nasdaq compliance risk.
Positive Factors
Resilient Gross Margin
Maintained gross margins indicate the core service can retain meaningful value per dollar of sales. If revenue stabilizes, this margin profile could support operating recovery, although current overhead remains too high for the business to reach profitability.
Negative Factors
Severe Revenue Contraction
The sustained revenue decline signals a major loss of operating scale and market traction. Lower sales reduce the ability to absorb fixed costs, making a return to profitability dependent on rebuilding demand or materially restructuring the cost base.
Read all positive and negative factors
Positive Factors
Negative Factors
Resilient Gross Margin
Maintained gross margins indicate the core service can retain meaningful value per dollar of sales. If revenue stabilizes, this margin profile could support operating recovery, although current overhead remains too high for the business to reach profitability.
Read all positive factors

Callan JMB, Inc. (CJMB) vs. SPDR S&P 500 ETF (SPY)

Callan JMB, Inc. Business Overview & Revenue Model

Company Description
Callan JMB Inc., operating primarily through its subsidiary Coldchain Technology Services, LLC, specializes in providing temperature-controlled logistics solutions specifically for the life sciences sector. The company's services include comprehen...

Callan JMB, Inc. Financial Statement Overview

Summary
Financials show severe deterioration: revenue has contracted sharply (about $22.8M in 2022 to ~$5.1M TTM), profitability flipped to deep losses, and TTM operating/free cash flow are deeply negative (roughly -$4.5M OCF and -$4.1M FCF). The balance sheet is pressured as equity has shrunk materially, driving very high leverage in TTM despite relatively modest absolute debt (~$2.1M). A partial offset is that gross margin has remained relatively healthy (~37–43%), but the current loss and cash-burn profile dominates.
Income Statement
18
Very Negative
Balance Sheet
24
Negative
Cash Flow
22
Negative
BreakdownTTMMar 2026Dec 2024Dec 2023Dec 2022
Income Statement
Total Revenue5.09M5.72M6.56M13.20M22.77M
Gross Profit2.03M2.10M2.56M5.65M9.45M
EBITDA-9.65M-7.81M-2.12M2.31M6.37M
Net Income-9.77M-7.97M-2.29M2.18M6.22M
Balance Sheet
Total Assets4.45M5.78M5.08M9.71M15.25M
Cash, Cash Equivalents and Short-Term Investments860.27K2.13M2.10M5.16M6.19M
Total Debt2.14M2.00M907.45K400.00K410.88K
Total Liabilities3.77M3.45M1.91M910.27K1.24M
Stockholders Equity681.86K2.33M3.17M8.80M14.01M
Cash Flow
Free Cash Flow-4.12M-5.16M494.19K6.51M8.94M
Operating Cash Flow-4.50M-4.55M540.35K7.00M9.36M
Investing Cash Flow-238.87K-616.90K-46.17K-490.02K-422.49K
Financing Cash Flow1.37M5.20M-3.55M-7.54M-4.57M

Callan JMB, Inc. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2.10
Price Trends
50DMA
4.34
Negative
100DMA
4.65
Negative
200DMA
Market Momentum
MACD
-0.26
Positive
RSI
29.52
Positive
STOCH
25.52
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CJMB, the sentiment is Negative. The current price of 2.1 is below the 20-day moving average (MA) of 3.85, below the 50-day MA of 4.34, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of -0.26 indicates Positive momentum. The RSI at 29.52 is Positive, neither overbought nor oversold. The STOCH value of 25.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CJMB.

Callan JMB, Inc. Risk Analysis

Callan JMB, Inc. disclosed 45 risk factors in its most recent earnings report. Callan JMB, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Callan JMB, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
54
Neutral
$68.74M-3.91-41.63%10.20%24.09%
51
Neutral
$12.08M-1.10-285.37%
44
Neutral
$7.14M-0.74-23.56%6.45%81.99%
40
Underperform
$13.18M-0.61-104.33%4.80%-102.00%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CJMB
Callan JMB, Inc.
2.20
-2.62
-54.36%
CRGO
Freightos Limited
1.30
-2.01
-60.73%
JYD
Jayud Global Logistics Limited Class A
0.93
-7.99
-89.62%
BTOC
Armlogi Holding Corp
0.29
-1.12
-79.57%
NCEW
New Century Logistics (BVI) Ltd.
18.39
13.47
273.76%
SLGB
Smart Logistics Global Limited
0.50
-3.02
-85.74%

Callan JMB, Inc. Corporate Events

Business Operations and StrategyExecutive/Board ChangesM&A TransactionsPrivate Placements and FinancingRegulatory Filings and Compliance
Callan JMB Announces Preferred-Funded Williston Basin Acquisition
Positive
Aug 24, 2026
On August 19, 2026, Callan JMB Inc. and its subsidiary Callan Power LLC agreed to acquire Reger Oil’s leases and related oil and gas assets in the Williston Basin for $12 million, paid through $10 million of Series A Perpetual Convertible Pr...
Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance
Callan JMB Expands Equity Line Financing Facility
Positive
Aug 20, 2026
On August 18, 2026, Callan JMB Inc. entered into a First Amended and Restated Purchase Agreement with an investor, expanding an existing equity line facility from $25 million to up to $75 million in common stock sales, exercisable through April 1,...
Delistings and Listing ChangesRegulatory Filings and Compliance
Callan JMB Faces Nasdaq Minimum Bid Price Noncompliance
Negative
Jul 2, 2026
On June 29, 2026, Callan JMB Inc. received notice from Nasdaq that its common stock had failed to meet the $1.00 minimum bid price requirement for the past 30 consecutive business days. The company’s shares will continue to trade under the C...
Executive/Board Changes
Callan JMB Announces Executive Vice President Eric Kash Resignation
Neutral
Jun 11, 2026
On June 5, 2026, Callan JMB Inc. announced that Executive Vice President and board member Eric Kash resigned from all his roles, with the company emphasizing that his departure did not stem from any disagreement over operations, policies or practi...
Private Placements and FinancingRegulatory Filings and Compliance
Callan JMB Launches ATM Equity Offering for Flexibility
Neutral
May 27, 2026
On May 26, 2026, Callan JMB Inc. entered into an at-the-market issuance sales agreement with Alexander Capital, L.P. that allows the company to sell up to $5 million of its common stock from time to time through the firm as sales agent. The shares...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 24, 2026